Singapore May be Shielded from US Pharma Tariffs, Gan Says
PositiveFinancial Markets

Deputy Prime Minister Gan Kim Yong has indicated that Singapore's drugmakers may not face immediate repercussions from the recent US pharma tariffs. This is significant as it suggests that the local pharmaceutical industry could remain stable while the government engages in discussions with Washington for further clarity on the new levies. Such proactive measures could help safeguard Singapore's economy and maintain its position as a key player in the global pharmaceutical market.
— Curated by the World Pulse Now AI Editorial System